American Society of Hematology, Blood, 13(126), p. 1595-1600, 2015
DOI: 10.1182/blood-2015-03-636761
Full text: Download
Key PointsUntargeted and targeted metabolomics showed association of low plasma acylcarnitines levels with venous thrombosis risk. Long-chain acylcarnitines are anticoagulants that inhibit factor Xa by binding to factor Xa outside the γ-carboxy glutamic acid domain.